Orion Portfolio Solutions LLC lessened its position in Colgate-Palmolive (NYSE:CL – Free Report) by 1.7% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 43,297 shares of the company’s stock after selling 753 shares during the period. Orion Portfolio Solutions LLC’s holdings in Colgate-Palmolive were worth $4,495,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently bought and sold shares of CL. Continuum Advisory LLC raised its holdings in Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after acquiring an additional 125 shares during the period. Reston Wealth Management LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive in the 3rd quarter worth $53,000. Prospera Private Wealth LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth $64,000. Finally, Gradient Investments LLC raised its holdings in Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after acquiring an additional 400 shares during the period. Institutional investors own 80.41% of the company’s stock.
Insiders Place Their Bets
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.37% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Price Performance
NYSE:CL opened at $92.95 on Tuesday. The firm has a market cap of $75.94 billion, a PE ratio of 26.63, a price-to-earnings-growth ratio of 3.36 and a beta of 0.43. Colgate-Palmolive has a 12 month low of $75.50 and a 12 month high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company’s 50-day moving average price is $96.33 and its two-hundred day moving average price is $98.65.
Colgate-Palmolive Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.15%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- What Are Dividends? Buy the Best Dividend Stocks
- How to Master Trading Discipline: Overcome Emotional Challenges
- Best Stocks Under $5.00
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- Financial Services Stocks Investing
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.